Tolerability of olaparib (OLA) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) and homologous recombination repair (HRR) gene alterations: PROfound

Roubaud G., ÖZGÜROĞLU M., Penel N., Matsubara N., Mehra N., Kolinsky M. P., ...More

ESMO Virtual Congress, ELECTR NETWORK, 19 September - 18 October 2020, vol.31, (Summary Text)

  • Publication Type: Conference Paper / Summary Text
  • Volume: 31
  • Doi Number: 10.1016/j.annonc.2020.08.883
  • Country: ELECTR NETWORK
  • Istanbul University Affiliated: No